Status | Study |
Recruiting |
Study Name: Swiss Primary Sclerosing Cholangitis Cohort Study Condition: Cholangitis, Sclerosing Date: 2017-05-08 |
Recruiting |
Study Name: A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2016-11-22 Interventions: Drug: Curcumin Subjects will receive one 750 mg softgel by mouth twice a day for 12 weeks. Each each 750 |
Not yet recruiting |
Study Name: A Study of Oral Hymecromone to Treat Adults With Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2016-05-17 Interventions: Drug: hymecromone hymecromone treatment as described |
Recruiting |
Study Name: Quality of Life in Patients With Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2016-03-11 Interventions: Other: quality of life survey subjects with PSC will be administered a survey to assess their quality of |
Active, not recruiting |
Study Name: Phase 2 Study of NGM282 in Patients With Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2016-02-29 Interventions: Biological: NGM282 Other: Placebo |
Recruiting |
Study Name: PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Subjects With Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2016-01-08 Interventions: Drug: Cenicriviroc 150 mg One tablet of CVC 150 mg once daily taken with food in the morning |
Recruiting |
Study Name: Effect and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis Patients Condition: Primary Sclerosing Cholangitis Date: 2015-10-31 Interventions: Drug: Vancomycin Vancomycin fo |
Recruiting |
Study Name: Fecal Microbiota Transplantation for the Treatment of Primary Sclerosing Cholangitis. Condition: Sclerosing Cholangitis Date: 2015-04-18 Interventions: Biological: Fecal Microbiota Transplantation |
Completed |
Study Name: Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC) Condition: Primary Sclerosing Cholangitis Date: 2014-09-05 |
Recruiting |
Study Name: A Trial of BTT1023 in Patients With Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2014-09-04 Interventions: Drug: BTT1023 IV (in the vein) Investigational Medicinal Product (IMP) |